EXOZYMES INC. cotiza a 5.05 USD y tiene una capitalización bursátil de $47M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, I…
| Métrica | EXOZ | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -269.6% | -40.4% | -229.2% |
| ROA | -153.4% | -32.0% | -121.4% |
| Current Ratio | 2.51 | 2.84 | -0.33 |
| Debt / Equity | — | 0.28 | — |